Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation

Baumgart, SJ; Nevedomskaya, E; Lesche, R; Newman, R; Mumberg, D; Haendler, B

Haendler, B (corresponding author), Bayer AG, Preclin Res Oncol, Mullerstr 178, D-13353 Berlin, Germany.

MOLECULAR ONCOLOGY, 2020; 14 (9): 2022

Abstract

Prostate cancer (PCa) is one of the most frequent tumor types in the male Western population. Early-stage PCa and late-stage PCa are dependent on andr......

Full Text Link